Global Intraocular Lens Market is expected to grow to US$ 6.11 Billion by 2030
27 Jan, 2024

Global Intraocular Lens Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis. The competition, geographic distribution, and growth potential of the Global Intraocular Lens Market are all examined in this study by Renub Research.

Global Intraocular Lens Market is anticipated to expand at a CAGR of 5.39% between 2024 and 2030. Intraocular lenses (IOLs) are implanted after a cataract surgical procedure to update the herbal lens, alleviating troubles like blurry vision. With cataracts being a common condition among the aging population in China and the United States, the IOL market is rapidly growing. Cataracts, inflicting vision impairment, necessitate IOL implantation, propelling market demand. Economic growth and multiplied disposable earnings prompt people to prioritize fitness, fostering a willingness to spend money on elective tactics like cataract surgical treatment and IOLs, contributing to market growth.

The IOL market is booming due to innovative improvements such as foldable and multifocal lenses and smart IOLs linked to devices. These advancements are revolutionizing vision correction and attracting more patients. Also, authorities' initiatives globally are essential in fostering market expansion by prioritizing accessible and cheap healthcare. Measures like more desirable insurance coverage for IOLs and dedicated national healthcare applications centered on enhancing eye health contribute to the general growth and improvement of the IOL market. So, the global intraocular lens market is expected to grow to US$ 6.11 billion by 2030.

Despite colossal development, the intraocular lens (IOL) penetration rate in numerous regions falls below expectations, indicating vast room for future growth, especially in developing countries. In tandem, key IOL producers are forging collaborations with research institutions and healthcare vendors to facilitate information sharing and create IOLs customized to meet patients' specific requirements. This collaborative effort strengthens the market atmosphere and improves and enhances the IOL industry.

Multifocal intraocular lenses (IOLs) are gaining market dominance, surpassing traditional mono-focal IOLs due to more visual freedom

Unlike their mono-focal counterparts, multifocal IOLs lessen dependence on glasses by providing clean, imaginative, and prescient vision at diverse distances, enhancing patients' independence. They additionally offer sharper vision at intermediate distances, enhancing comfort for daily activities. Technological improvements and progressed designs and materials lessen side effects like glare. A more significant type of multifocal IOL alternatives, personalized for precise patient needs, further contributes to their enchantment, growing the patient's delight and reputation.

Hydrophobic and hydrophilic acrylic materials lead the global intraocular lens (IOL) market

The growth of the material is due to its versatility in growing numerous IOL designs and serving multiple patient needs. Acrylics, including monofocal, multifocal, myopic, and toric lenses, address various market demands and cater to an extensive patient spectrum. Compared to substances like silicone, their cost-effectiveness expands accessibility to a more extensive patient base, promoting market penetration. With a verified tune report of protection and long-term performance, acrylic IOLs instill agreement and confidence amongst surgeons and patients, further solidifying their market dominance.

Report Details:

Hospitals overpower the worldwide intraocular lens (IOL) market

Skilled surgeons and advanced centers, such as sophisticated systems, inspire self-assurance in patients. Hospitals offer complete care, masking pre-operative consultations, surgical procedures, and post-operative assistance to ensure seamless continuity. Emergency preparedness and established logistics contribute to patients' well-being and cost-effectiveness. Leading hospitals requires research and innovation, participating in scientific trials, and educating future experts. This proactive engagement keeps hospitals ahead in presenting modern-day IOL technologies and advancements, fostering non-stop improvement in the discipline.

China intraocular lens (IOL) market is set to experience enormous growth

The surge in the market is because of demographic shifts, improved healthcare consciousness, and supportive government policies. China's growing older population, exceeding 260 million, exceeding 60 and older, contributes to elevated cataract cases necessitating IOL implantation. The state's burgeoning economy, increasing disposable earnings, and growing healthcare focus empower individuals, particularly older people, to choose cataract surgical operations with IOLs. Government projects, elevated medical insurance, and investments in healthcare infrastructure toughen the market. Technological advancements, along with foldable and multifocal lenses, enhance surgical effects. China's attention to domestic IOL producers signals untapped capability for future market enlargement.

Competitive Landscape

In the intraocular lens market, the few companies with the largest revenue share are Novartis AG, Johnson & Johnson, Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, and STAAR Surgical Company.

Market Summary

• Product – A Renub Research report on the Global Intraocular Lens Market looks at products from four angles (Monofocal IOL, Multifocal IOL, Toric IOL, and Accommodative IOL).
• Materials – A Renub Research report on the Global Intraocular Lens Market looks at materials from four angles (Polymethyl meth Acrylate Material, Silicone Material, Hydrophobic & Hydrophilic Acrylic Material, and Other Materials).
• End-Users – A Renub Research report on the Global Intraocular Lens Market looks at end-users from four angles (Hospitals, Ambulatory Surgery Centers, Ophthalmology Clinics, and Eye Research Institutes).
• Countries – A Renub Research report on the Global Intraocular Lens Market looks at countries from six angles (North America (including the United States, Canada, and Mexico), Latin America (including Brazil), Europe (including the United Kingdom, Germany, France, Italy, Spain, and the Netherlands), Asia Pacific (including China, Japan, India, South Korea, and Australia), Middle East & Africa (including South Africa and the United Arab Emirates), and Rest of the World).
• Key Players – Every significant player in the Global Intraocular Lens Market has been discussed from three perspectives (Overview, Recent Developments, and Revenue) Novartis AG, Johnson & Johnson, Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, and STAAR Surgical Company.

About Us

Renub Research is a Market Research and Consulting Company. We have more than 14 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.

Contact Us
Renub Research
Phone: +1-478-202-3244 (USA) | +91-120-421-9822 (IND)
Email: info@renub.com
Web: https://www.renub.com
Follow on Linkedin: https://www.linkedin.com/company/renub-research